Cargando…
Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions
SIMPLE SUMMARY: Glioblastoma multiforme is a futile disease usually leading to the patient’s death within one year post-diagnosis; therefore, novel treatment options are desperately needed. In this regard, activation of the inert immune system has moved into focus in recent years. Malignant brain tu...
Autores principales: | Bitar, Lynn, Schumann, Ulrike, König, Renate, Zipp, Frauke, Schmidt, Mirko H. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306848/ https://www.ncbi.nlm.nih.gov/pubmed/34298735 http://dx.doi.org/10.3390/cancers13143524 |
Ejemplares similares
-
Gamma Irradiation Triggers Immune Escape in Glioma-Propagating Cells
por: Hoppmann, Nicola, et al.
Publicado: (2022) -
The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens
por: Mahajan, Sukrit, et al.
Publicado: (2023) -
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
por: Brummer, Tobias, et al.
Publicado: (2021) -
The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017) -
EGFL7 loss correlates with increased VEGF-D expression, upregulating hippocampal adult neurogenesis and improving spatial learning and memory
por: Barth, Kathrin, et al.
Publicado: (2023)